Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Am J Cardiol. 2011 Nov 24;109(3):370–377. doi: 10.1016/j.amjcard.2011.09.023

Table 2.

Association of warfarin use with all-cause mortality

Events (%) Absolute
risk
difference*
Hazard ratio
(95% confidence
interval)
P
value
No warfarin Warfarin
All-cause mortality
   Before matching (N=2248) n=347 n=1901
     Unadjusted 97 (28%) 365 (19%) − 9% 0.71 (0.57–0.89) 0.003
     Multivariable-adjusteda --- --- 0.70 (0.54–0.91) 0.007
     Propensity-adjustedb --- --- 0.67 (0.52–0.87) 0.003
   After matching (N=843) n=227 n=616
     Propensity-matched 74 (33%) 112 (18%) − 14% 0.58 (0.43–0.77) <0.001
*

Absolute risk difference was calculated by subtracting the percentage of events in the warfarin group from that of the no-warfarin group (before values were rounded)

a

Adjusted for all 45 baseline characteristics

b

Adjusted for propensity score.